BioSapien Inc.
PrivateLast Round
VC Round
Jul 7, 2025
Total Funding Raised
$15.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioSapien Inc. is a biotechnology company that develops 3D-printed, biodegradable mesh chips designed to deliver pharmaceuticals directly to tumor sites.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSapien Inc. Comparables
Compare BioSapien Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 89% | |
| RenovoRx | 75% | |
| NanOlogy, LLC | 74% | |
BioSapien Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 7, 2025 | ||||
| Early Funding | Jan 27, 2025 | ||||
| Early Funding | Dec 12, 2024 | ||||
| Seed | Nov 11, 2021 | ||||
| Grant | Jun 30, 2021 | ||||
Grant | May 1, 2021 |
BioSapien Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Golden Gate Ventures | Early Funding, VC Round |
| JPIN 1 | VC Round |
| Global Ventures | Early Funding, VC Round |
| Dara Holdings | Early Funding, VC Round |
| Side Door Ventures | Seed |
| Dara Management | Early Funding |
| Globivest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Grew 30% QoQ from 10 to 13 employees.
- Jul 7, 2025
$1M round led by Globivest
BioSapien Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioSapien Inc.'s valuation, stock price, and market status.